Welcome! This blog contains research & information on lifestyle, nutrition and health for those with MS, as well as continuing information on the understanding of the endothelium and heart-brain connection. This blog is informative only--all medical decisions should be discussed with your own physicians.

The posts are searchable---simply type in your topic of interest in the search box at the top left.

Almost all of MS research is initiated and funded by pharmaceutical companies. This maintains the EAE mouse model and the auto-immune paradigm of MS, and continues the 20 billion dollar a year MS treatment industry. But as we learn more about slowed blood flow, gray matter atrophy, and environmental links to MS progression and disability--all things the current drugs do not address--we're discovering more about how to help those with MS.

To learn how this journey began, read my first post from August, 2009. Be well! Joan

Showing posts with label ISNVD. Show all posts
Showing posts with label ISNVD. Show all posts

Tuesday, December 1, 2015

Moving forward

Research into the vascular connection to MS is continuing and expanding in scope.  I am heartened to see one particular group of researchers growing in size and addressing many new discoveries.  The ISNVD is moving forward.

The program and registration for the 2016 International Society for Neurovascular Disease 6th Annual Science Meeting is now online.
http://www.isnvd.org/newyork

From the announcement:
We are proud to announce that the 6th annual ISNVD scientific meeting will take place in lower  Manhattan, New York City on April 29th and April 30th of 2016.
During the past few years, the field of neurovascular disease has witnessed a vast growth in clinical and translational research. 

One of the most exciting revelations in this "vast growth" will be presented by keynote speaker, Dr. Jonathan Kipnis from the University of Virginia.  Dr. Kipnis will be presenting on his lab's landmark discovery of the brain's lymphatic vessels in "The Brain Drain, Meningeal Lymphatics and Neurological Disorders."  You might remember the attention his research received in Scientific America and the medical press, when headlines proclaimed the existance of a link between the brain and immune system.  

Here's more on this "stunning discovery."

As the Journal of Experimental Medicine stated, it is time to "rewrite the textbooks."

Why does Dr. Kipnis' research matter?  Because he has discovered that the brain's immune system relies on the veins which drain the brain.   

Other recent research, like Gladstone Labs discovery that a drop of blood can instigate an MS-like immune reaction in the brain, is important in light of opening day topics such as Dr. Alireza Minegar's discussion of "MS as a Vascular Disease" and Dr. Chih-Ping Chung's presentation on cerebral micro bleeds.

And there will be much discussion on clinical trials for treatment, as specialists from Italy, the US, Australia, and Bulgaria will speak about their treatment trials for vascular interventions in neurovenous disease.  

Here is the program:

As we learned in 2015, the brain is not immune privileged.  It is connected to the body's lymphatic system by vessels which rely on veins for drainage.  We also learned that it does not take an "autoimmune" reaction to cause MS.  As in stroke or traumatic brain injury,  all that is needed is to initiate myelin-destroying inflammation is plasmic particles breaking through the blood brain barrier.  These discoveries point to the undeniable connection of the brain to the vasculature.

The current resistance to this very real connection and dogged insistance on the 80 year old mouse model of multiple sclerosis is holding back research.  It will be independent groups, like the ISNVD and Gladstone Labs, who will break through the pharma-controlled impasse in MS research, and find real solutions, based on current scientific evidence.

In the meantime;  live your best, heart-healthy life.  Don't smoke, move your body every day, eat nutritious whole foods, manage stress, get sunshine and supplement Vitamin D and B, if warranted.  There are things you can do today to help your brain heal.  

Don't believe me?  Just check out Dr. Norman Doidge's new, NY Times Bestseller book, 
The Brain's Way of Healing    

They thought that the brain
was too sophisticated for its own good.
That during evolution it became so complex
that it lost the ability to repair itself and
to restore lost functions
or to preserve itself.
They were wrong.
Because it turns out that its very sophistication
can be the source of a unique kind of healing…
The brain’s way of healing…


Here's to moving forward, and leaving the old, incorrect assumptions behind.

Joan


Wednesday, August 5, 2015

MS News--It's deja vu, all over again

Following neurology headlines since Jeff's MS diagnosis 8 years ago--I've seen many exciting research developments in understanding the human brain.

Recent examples of game-changing research include
The discovery of the brain's lymphatic cleansing system, which occurs when we sleep.
http://ccsviinms.blogspot.com/2015/04/glial-cells-glymphatics-and-nedergaard.html

The discovery of the brain's lymphatic vessels, which mean that the brain is not immune privileged, and immune cells are needed in the CNS to insure brain health.
http://ccsviinms.blogspot.com/2015/06/rewrite-textbooks.html

And all of the discoveries made into the vascular connection to diseases of neurodegeneration published by the International Society for Neurovascular Disease (ISNVD)
http://ccsviinms.blogspot.com/2015/03/2015-isnvd-conference-abstracts.html

Meanwhile, MS research spins on a hamster wheel of repetition and dismal lack of progress.  It's been the same, sad headlines for the past eight years.   Nothing about disease etiology.  There is a complete disconnect between what is happening in neuroscience, and what is happening in MS treatment.

Here are today's MS "News" headlines--- (we've seen these over and over again)

PML, the deadly reaction to the JC virus found in immune-compromised individuals, is now being diagnosed in patients on MS drugs Tecfidera, Gilenya and Tysabri.
http://www.medpagetoday.com/Neurology/MultipleSclerosis/52930

White matter lesions are not meaningful in understanding MS progression, and gray matter disease is more closely tied to disability progression.
http://www.nature.com/nrneurol/journal/vaop/ncurrent/full/nrneurol.2015.140.html

Salt, lack of vitamin D and environmental factors like smoking contribute to MS progression, but MS specialists are not sure why.  Even though cardiovascular researchers already know these factors all contribute to endothelial dysfunction.  The heart-brain connection is continually ignored by MS research.
http://www.eurekalert.org/pub_releases/2015-08/foas-hsi080515.php
http://www.independent.co.uk/life-style/health-and-families/five-ways-to-boost-your-vitamin-d-levels-10437766.html
http://www.mstrust.org.uk/news/article.jsp?id=6850

And in a bumbling show of complete disregard for the cardiovascular connection to brain health, the MS Society of Canada asks Canadians to pledge to eat super-sized portions of french fries to "EndMS"!!!!!  You could not write this stuff, folks.   Simply unbelievable.
http://www.weightymatters.ca/2015/08/multiple-sclerosis-society-of-canada.html





What I find most troubling is that nothing has changed the $20 billion dollar a year MS treatment machine.  Drugs with harmful side effects, which calm inflammation but DO NOT address gray matter loss or disease progression, continue to be prescribed as "gold standard" treatment.    Patients are not being told that lifestyle changes-- such as exercise, vitamin D supplementation and UV ray exposure, whole food nutrition, limiting processed foods and transfats, not smoking, and getting good sleep--are all scientifically shown to make a difference in disease progression and calm inflammation in a less risky way.  Advocates who try to help people understand this, like Matt Embry, are sent cease and desist copyright infringement letters by the MS Society.  And no one, with the exception of the ISNVD and Dr. Zamboni, and advocacy groups like CCSVI Alliance, Direct-MS and the NCS, is discussing the vascular connection to MS.

MS research labs are funded, MS specialists get their speaking and consultation fees from pharma, the stock market and investors continue to follow MS drugs, MS Society leaders are paid, funds are raised from people eating french fries---- money is being made off of MS patients.
Yet no one is pursuing disease etiology.

I've talked to many researchers over these past years, and they are all frustrated by the lack of initiative and funding available to them.

Jeff and I are traveling, working, back to our careers and lives.  I keep blogging, hoping that drawing attention to research on the vascular connection might help someone.  Every month or so, I check the MS research headlines, and see the same ol' same 'ol.  Deja vu, all over again.

In the next few months, I will be posting links to my new podcast.  It will feature interviews with doctors and researchers who are passionate and committed to helping people heal.  I'll have more information available as I get further along in the process.  It will be available, for free, on iTunes and linked on a webpage.

I do not want to see the same stagnating MS headlines and failed treatments eight years from now--and I know none of you do, either!  We owe it to this wonderful MS community, we owe it to our children and their children.  If you have ideas for doctors, researchers or topics you'd like to hear addressed, please leave me your suggestions! I'll be speaking to functional medicine doctors, researchers and advocates.

Let's all be the change we wish to see, and get off the hamster wheel,
Joan



Saturday, November 8, 2014

Genetics and MS

Every few months, there is a news story lauding the fact that researchers have finally verified that MS is autoimmune.  These stories have a similar theme.  MS is most certainly autoimmune, because the connections made between MS and genes are all found in the immune system.  

But that's because it is the only place researchers are looking.  The major histocompatilbility complex (MHC) region remains the area under exploration, now 40 years since its initial discovery.

And they continue to get research grants from pharmaceutical companies to continue to look at the same location, because making this connection to the autoimmune theory advances drug sales.

In fact, the connection to heretability and genetics in MS is rather slim.  In identical twins, genetic risk is less than 1/3 if one twin has MS.  

...there is a 2% to 4% elevated genetic risk in siblings of patients with MS and a 30% greater risk in identical twins.
http://www.medscape.com/viewarticle/833070



There was a recent story in the NY Times regarding research into a potential genetic link found in those who die due to Ebola infections.  Researchers Angela L. Rasmussen and Michael G. Katze of the University of Washington  found a problem with blood vessels, which were allowing immune cells open access and an overblown reaction to the virus. That's right.  Death from Ebola happens because of a break down of the endothelium, or the lining of blood vessels.  And there is a potential genetic link.
http://www.nytimes.com/2014/10/31/health/genes-influence-ebola-infections-in-mice-study-suggests.html?_r=1

About two-thirds of people who die from Ebola never develop the terrifying hemorrhages that appear in others a day or two before death, in which eyes turn fiery red, gums bleed, red dots emerge on the skin as blood seeps out of capillaries, and blood appears in vomit and diarrhea. Many mice, too, die of Ebola without hemorrhages.

The mouse studies indicate the animals that hemorrhage and — by implication, humans— die because their immune systems overreact to the virus. The result is an inflammatory response that makes cells leak fluids and white blood cells, and makes tissues and organs deteriorate. Many die at that point. In those mice — or humans — that survive long enough, the researchers propose, blood eventually starts to seep out of vessels.

In fact, researchers found a genetic link to two specific genes, which were allowing for the overblown inflammatory response.


The mouse studies showed that animals that died after bleeding had an overblown inflammatory response to the virus. They also had low activity of two genes, Tie1 and Tek, that made their blood vessels more permeable. The leaky vessels allowed white blood cells to stream out, escalating the inflammatory response and causing a chain reaction of damaging immune system chemicals that destroyed organs. 


She said that “a big take-home lesson from the paper” is that genetics plays a major role in determining the outcome of a mouse’s Ebola infection. By inference, she said, genetics probably plays the same role in humans.


(for those who enjoy learning more, here is a paper on how Tie1 and Tie2 (TEK) are involved in vascular permeability.)
http://www.bloodjournal.org/content/93/6/1969?sso-checked=true



An overblown inflammatory response due to a breakdown of the lining of the blood vessels.  Sounds like something MS researchers might want to investigate, especially considering the recent research of Dr. Yulin Ge of NYU.

At the ISNVD conference in February 2014, Dr. Yulin Ge discussed how 7T MRI technology is allowing us to see tiny hemorrhages in the MS brain which occur before demyelination.  This further elucidates the microvascular connection to MS.
From his abstract at the ISNVD:

Being the most common demyelinating disease of the central nervous system, multiple sclerosis (MS) MS has a significant microvascular pathological component as a consequence of the perivascular inflammation. The role of vascular pathology in MS was suggested long ago. Now there is accumulating evidence of a primary vascular pathogenesis in MS. In vivo studies of vascular and hemodynamic impairment in MS may provide insights into the etiology and pathophysiology of MS and offer the potential metrics for assessment of outcome of the disease. 

The definition of insanity is repeating the same act over and over and expecting different results.  Continually searching in the same place for a genetic link to MS is not bringing us any closer to understanding MS aetiology.  It's making money for research labs and drug companies, but it is not bringing health and healing to people with MS.

Thanks to the ISNVD, for looking beyond the autoimmune paradigm.
Joan





Friday, January 3, 2014

Dallas Buyers Club and MS treatments

One of the new Oscar-worthy movies now in theaters is Dallas Buyers Club.  It features tour de force acting and a compelling, true-story script.  Jeff and I both enjoyed this film, for a variety of artistic, professional and personal reasons.

I don't want to give away spoilers for those who haven't seen the movie.  With that caveat, if you're planning on seeing the movie and don't want to know what it's about, stop reading now, and come back to this note after you've seen it.

Personally, I don't like to know anything about a movie before I see it--which is why I hate movie trailers.  I steer clear of movie and book reviews for the same reason.  So, if you're like me, and you enjoy being surprised when you see a film--stop now :)



SPOILERS AHEAD.....(OK, that was your final warning!)

+++++++++++++++++++++

What I didn't realize, when Jeff and I recently saw this film, is that this is a true story about Ron Woodruff's fight for his life.  Ron battled for the right to purchase and distribute alternative treatments, which at that time were not FDA approved.  His heroic effort was profiled in a 1992 feature article, written by Bill Minutaglio and published in the Dallas Morning News.  This is highly recommended reading.

Ron was diagnosed with HIV in 1985.  He was a rough-talking, rougher-living, drug-addicted rodeo rider, and by the time he'd received his diagnosis, he was given 30 days to live.  His treating doctors were unable to help him, since they were conducting a double blind, placebo controlled trial for AZT, which was at that time the only FDA approved anti-retroviral available to treat HIV.  Ron set about getting AZT for himself, by paying a hospital employee to steal it for him.  When he was no longer able to get AZT, he set out to learn more about how he could help himself. Ron began to research alternative treatments at the local public library and at HIV support groups.   This was in the days before the internet, and our current access to online medical journals and support groups.  This research lead him across the border to Mexico, where he worked with a physician to create a different protocol to treat his HIV.  The doctor in Mexico explained to Ron that the AZT he had been taking had actually been causing serious side-effects, like anemia and neuropathy.  Ron was close to death by the time this doctor helped him find less toxic ways to deal with his HIV.

At that time, the few HIV treating doctors in U.S. hospitals were blocking their patients from using alternative treatments.  Other anti-viral treatments and supplements were considered safe, proven to help those with HIV, and available to patients in other countries, but because US doctors and the pharmaceutical industry needed their patients "treatment naive" for clinical trials of AZT, these alternatives became illegal.  Sadly, many trials noted problems with the toxicity and side effects of AZT.  Some of these studies had been published in medical journals in other countries, but were being withheld from the US doctors.  A key scene in the movie is when Ron brings a copy of the medical  journal, The Lancet, to his treating doctor, and shows her studies mentioning the deadly side effects and lack of efficacy with AZT that have been silenced in the US. 

In 1987, Ron begins smuggling drugs across the border and selling them to other HIV patients.  This effort to save his life and help others begins the Dallas Buyers Club.  I was happily surprised to learn that some of the supplements in the protocol he sold included silymarin (milk thistle), natural antivirals, and omega 3 oil (part of the Endothelial Health Program.)  These "buyers clubs" were set up around the country, to help thousands of  AIDS patients deal with their symptoms and to give them quality of life-- by selling them hundreds of alternative treatments, many of which were brought into the US illegally.  These treatments extended the lives of thousands of people with HIV, often by many years and even decades past their expected life span on AZT alone.  In fact, a virtual anti-viral cocktail and other supplements has now become the accepted form of treating HIV, thanks to the efforts of these first patients.  HIV is no longer a death sentence, because of the work of these heroes.  I'd forgotten the history of this era--it was a time when AIDS patients would protest outside the FDA office in Washington, calling for faster approval of treatments to slow the disease.  And all the while, the FDA stood firmly behind one treatment and one means of disease modification--AZT.  Here's the interesting history regarding how AZT, a drug created to fight cancer which failed in cancer trials, which was later developed for use in HIV thanks to a unique, and perhaps questionable, partnership between the National Cancer Institute and Burroughs Wellcome,  a drug company focused on anti-retroviral medications. http://www.scribd.com/doc/92129927/The-History-of-Zidovudine-AZT-Partnership-and-Conflict 

Here's a terrific write up of this film, and what it says about our current situation with FDA approval for drugs, published in Forbes.

What’s amazing is that in a country founded by wise men wholly skeptical of government, we live in a nation today that says it’s illegal for the terminally ill to do all they can to extend their lives. It’s easy to simply blame the FDA, the film does just that expertly, but the pharmaceutical industry itself shares some of the blame too. Names and companies will not be mentioned, but this writer remembers talking to a Washington representative of a big pharmaceutical company back in 2004, and in the conversation the FDA’s anti-life ways were mentioned.

The latter is almost a tautology considering the drug approval process that the FDA has erected, but the pharmaceutical rep lauded the bureaucracy. It was surprising at the time, but only initially. Figure if one of those innovative thinkers cures cancer tomorrow, that person’s ability to bring the drug to market will be impossible thanks to the FDA. Big pharmaceuticals like the FDA precisely because it protects a large market for them, and its approval process ensures that any cure crafted outside a government-infused pharmaceutical establishment will have to be sold to a well-connected drug company if it is to ever be used for its real purpose: the saving of lives.


To those of us working for alternative treatments and understanding of the disease process of Multiple Sclerosis,  this movie is all too real.
The parallels to the history of AZT/AIDS and the FDA approved treatments for multiple sclerosis are striking.  

1. The fact that negative studies for drugs are often shelved, and only positive studies are used to prove efficacy, is incredibly concerning.  There was a story just today from the BBC on how the lack of transparency in drug trials causes important data to be withheld from prescribing doctors.  
We see this in the MS drug world, as pharma-sponsored MS specialists promote their particular drug, while maintaining the misinformation that these drugs slow disability.  The numerous studies and neurologists who speak out on this fact and debate the EAE model of MS (Tremlett, Chaudhuri, Behan, Ebers) are ignored.

2.  The fact that alternative treatments and alternative disease modalities are portrayed in pharma-sponsored medical journals as pseudo science without referencing the positive studies.  We've seen this with CCSVI diagnosis and treatment, stem cell treatments, hyperbaric oxygen treatment, nutrition and lifestyle treatment, and all of the cardiovascular treatments that have been helping people with MS live longer and healthier lives for decades.  Dr. Swank's clinical trials from the 1950s showed how diet and lifestyle could give people with MS healthy remission and slow disease progression.  Yet it is only in the past 5 years that MS specialists even mention the importance of whole food diets, smoking cessation, antioxidant rich diets, and cardiovascular exercise to their patients.  For 60 years, the EAE mouse model of MS remains the only acceptable explanation for MS, yet an antigenic target has never been discovered.

3.  The fact that deadly side effects are down-played to maintain a drug's viability in the marketplace.  It's all about maintaining market share and stock value.  We see this with Tysabri, as MS specialists speak only of the "great benefit" of this drug, without discussing the growing numbers of those who now have the deadly brain virus, PML.  EHealthMe.com, a completely independent drug monitoring health care site, was created to combat this very problem, as it gives REAL numbers for side effects of drugs, and accepts NO pharma sponsorship.  And the site now reports that PML numbers for those on Tysabri are at 3%.  2,583 patients out of the 90,291 on Tysabri reporting side effects.

4. The fact that people with MS are forced to travel the globe and pay out of pocket for alternative treatments, many of which have published literature behind them, showing efficacy in relieving MS symptoms and slowing disability.  MS patients are treated like outlaws when they return home, and are denied follow up care, or actually fired by their physicians.

5.  The fact that patients are dying, every day, due to complications from MS.  Billions of dollars are made by the MS drug companies, yet we are no closer to understanding MS disease aetiology than we were when Thomas Rivers created the EAE mouse model in the 1940s.


For those who have seen the film, I'd love to know your thoughts.  Please comment below.  
Do you think we can get more journalists, documentary or dramatic film makers interested in the MS/CCSVI story?  How can we do this?

This past year, Jeff and I have seen how one film can change peoples' minds.  Jeff scored the new documentary, Blackfish, which is causing people to re-think whales as circus entertainment, and whether it is right to keep these majestic creatures in captivity.  We've seen a collective change of mind and heart, as people around the globe are protesting SeaWorld and petitioning to have orcas released to open sea-pens. Famous musicians cancel their appearances at SeaWorld, people boycott the marine parks, a little girl sits down in front of the SeaWorld float at the Rose Parade in protest, and is arrested by police in riot gear.    We've seen how much corporations are willing to fight back to keep their market share and stock value, as SeaWorld rigs polls on the internet, makes Forbes.com take down a critical editorial, and spends millions taking out full page ads claiming the documentary is not based on science.  Meanwhile, SeaWorld refuses to go on camera at CNN and discuss the facts.  The director of Blackfish asked them several times to be in her film.  She never had an "angle",  she just wanted the truth.  But they refused her, too.  We know, because we saw this film being made.  It's all true. 

My hope, in 2014, is that we can continue to change the dialogue.  That we can open peoples' eyes to the power and influence of the pharmaceutical industry.  That we can bring together physicians, patients and the public to look at meaningful ways to treat diseases of neurodegeneration.  That we can encourage writers, film makers, documentarians, news reporters, journalists, law makers, politicians, and scientists to look at the facts.  Not just the negative spin regarding the vascular connection to MS, which is often published in neurological journals---but the hard science coming out of collaborative, non-pharma sponsored groups like the International Society for Neurovascular Disease and the papers being published in vascular journals.

Let's get it done,
Joan


Thursday, February 2, 2012


CCSVI and the blood brain barrier--new research

February 2, 2012 at 8:56am

New research is showing us how the blood brain barrier functions.  Our understanding of what this barrier is and how it works has changed.

We may not see this happening in our neurologists' offices, or in the press, but it is important to understand that independent researchers (those with no connection to pharma) are looking at how CCSVI impacts the blood brain barrier.  I want to share this as encouragement. 

This is from an article written by K.K. Jain, MD on Medlink.  It was originally released in 1998, but Dr. Jain updates this article, as new research emerges.  The last update was in 2011.  
And now it includes CCSVI.  
Professor Jain is a nanotechnology and neurological expert, and serves as associate editor of Medlink Corporations online encyclopedia of neurology.

For over a century it has been recognized that the entry of certain substances into the brain is restricted. The old concept of the blood-brain barrier as a passive, impermeable barrier that segregates blood and brain interstitial fluid is giving way to the idea that the blood-brain barrier is a dynamic conduit for transport between blood and brain of those nutrients, peptides, proteins, or immune cells that have access to certain transport systems localized within the blood-brain barrier membranes.

When the BBB was first described in the 1800s, it was thought to be an impassible wall between blood, cerebrospinal fluid and brain tissue.  But we now understand:

 Key points
  • The blood-brain barrier is an important conduit of nutrients and cells from the blood to the brain.
  • It also has an important function in protecting the brain from the entry of harmful substances.
  • Knowledge of impairment of permeability of the blood-brain barrier in various neurologic disorders is important in understanding the pathomechanisms and devising strategies for management.
  • Permeability of the blood-brain barrier is manipulated for drug delivery to the brain.

Contrast-enhanced MRI in patients with multiple sclerosis show that increased permeability of the blood-brain barrier commonly occurs with this disease. Lymphocyte recruitment into the brain across endothelial cells of the blood-brain barrier, which is otherwise restricted and well regulated, represents a critical event in pathogenesis of multiple sclerosis (Correale and Villa 2007). The changes in capillary permeability often precede T2-weighted MRI evidence of tissue damage. Increased gelatinase B (a type of matrix metalloproteinase) is associated with an open blood-brain barrier on MRI. Steroids may improve capillary function by reducing activity of gelatinase B.

  Various inflammatory factors produced by perivascular cells in multiple sclerosis affect the permeability of the blood-brain barrier. One of these, the intercellular adhesion molecule-1, binds to its leukocyte ligands and allows activated leukocytes entry into the central nervous system. According to 1 hypothesis, pathological reflux of venous flow in the cerebral and spinal veins increases the expression of intercellular adhesion molecule-1 by the cerebrovascular endothelium, which, in turn, could lead to increased permeability of the blood-brain barrier (Simka 2009).



Specialists of the blood brain barrier and cerebral endothelium understand CCSVI.

Monday, January 9, 2012


Perspective

January 9, 2012 at 11:27am

In reading postings on the internet, checking in on the CCSVI advocacy groups, and trying to assess what's going on, it's easy to be discouraged these days.

The science and investigation of venous malformations in MS is moving too slowly for many.  People with MS have to deal with their progressive disease and time limitations.  The language of many MS specialists and neurologists is inflammatory and negative towards this research.  There are misguided and badly researched stories in the media.  Or complete oblivion of the vascular research and cheerleading for the pharmaceutical industry in the media.  There are allegations made between groups of people who should be working to help others. There are medical and tourism organizations looking for ways to make money off CCSVI.  Calls of quackery, angry words, hateful speech, negativity.  Lots of drama going on.

and it's discouraging.

But underneath all of the commotion, there is actual progress being made in understanding multiple sclerosis.

I want to try and focus on the progress and the positive today, and give some perspective, for my own spirit, as well as for others.  Because MS is our common enemy.  It is why we're here.  Life has enough drama.

Here is the explanation of the importance of the upcoming International Society for Neurovascular Disease (ISNVD) convention from the program--

 The meeting as a whole will primarily focus on advancing understanding of the recently described condition called CCSVI and its relationship to multiple sclerosis, other neurologic disorders and aging. A great amount of fresh and original information will be presented on this condition. Included are 5 scientific sessions on CCSVI that will further discuss the role of imaging techniques, diagnostic guidelines and standard consensuses to be used for diagnosing CCSVI.

Of particular interest is the session reporting first postmortem study results that assessed jugular and azygos venous pathology. Dr. Fox from the Cleveland Clinic will present some of his recent findings. Basic scientific and hemodynamic contributions, lectures and abstracts on the CCSVI hypothesis are sure to generate a significant level of interest among the participants. In particular, the session about computational fluid dynamics and measuring flow is aimed at attracting most of the conference attendees.

Saturday, March 12, 2011


Bologna---18 months later

March 12, 2011 at 10:18am

To those who are new to the page, or those who may not have read the notes from the first Bologna  CCSVI conference when they were posted in September 2009, I'm linking them here:


This coming week many of the same doctors are reconvening in Bologna to discuss ongoing studies of CCSVI.  When I was invited to the first conference in 2009, Dr. Zamboni asked me if I could help out by inviting some press from the US to cover the meeting.  I called all of my press contacts, as well as several medical writers. None were available.  One medical writer yelled at me for calling and bothering her.  She  told me "no one is interested in this."  Her big medical story the week I called was Steven Tyler falling off stage and breaking his arm.  I told her she was wrong, people were interested.  

Things are different in 2011.  People with MS, their caregivers, doctors and activists around the world have focused a light on the proceedings in Bologna.  It turns out that people are interested in CCSVI.  Very interested.  

As the doctors reconvene and discuss all that they have learned in 18 months, as new doctors step up to the podium and bring innovative perception to the research, I'll be at home with my family.  I don't need to fly by myself to cover the meeting and post it online, because there will be many more witnesses.  There will be international press and a host of participants transcribing the presentations.  And that makes me very, very happy.

Thanks to Dr. Zamboni for continuing the research, in the face of some very powerful opposition.  Thanks to all of the doctors who have taken up this cause.  Thanks to all of you for researching, reading and sharing this information.  Thanks to those who have reached for the baton and are running forward, so I can go to a concert, make dinner, go to church, walk the dog and enjoy my weekend with my husband and son in sunny California.  And to all those in Italy, make sure to step outside during breaks, walk the lovely ancient streets and have a gelato!

Here is the link to the International Society of Neurovascular Disease site and information about the conference next week:

Stay tuned.  As reports come in from the meetings, we'll be posting them all over the internet.  And who knows?  Maybe that medical writer will discover that people really do care about Multiple Sclerosis and the vascular connection.

Joan